Perforating dermatosis associated with multikinase inhibitors: report of two cases, including one associated with lenvatinib

J Dtsch Dermatol Ges. 2018 Dec;16(12):1486-1489. doi: 10.1111/ddg.13704. Epub 2018 Nov 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abdomen
  • Aged
  • Carcinoma / drug therapy
  • Carcinoma / secondary
  • Carcinoma, Hepatocellular / drug therapy
  • Folliculitis / chemically induced*
  • Folliculitis / pathology
  • Hand-Foot Syndrome / etiology
  • Humans
  • Liver Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Phenylurea Compounds / adverse effects*
  • Protein Kinase Inhibitors / adverse effects*
  • Quinolines / adverse effects*
  • Skin Diseases / chemically induced*
  • Skin Diseases / pathology
  • Sorafenib / adverse effects*
  • Thigh
  • Thyroid Neoplasms / drug therapy
  • Thyroid Neoplasms / pathology

Substances

  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Quinolines
  • Sorafenib
  • lenvatinib

Supplementary concepts

  • Elastosis perforans serpiginosa